PFSA — Profusa, Inc. Common Stock
Chart, dilution, float and news for PFSA in the TickerWise workspace.
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ Global Market
- Employees: 2
- Website: https://profusa.com
Latest SEC filings for PFSA
Latest PFSA news
- Premarket Movers: GCTK and PFSA Among Gainers, ARTL and BENF Among Losers Read article
Educational tool only — not investment advice.